On this page, we show you all research publications of the TIMESPAN consortium. These publications report on the research output of the project. For each publication, we provide a brief summary. To read the full article, imply click on the title of the publication.
TIMESPAN publications
2023
- Biederman J, DiSalvo M, Green A, Hutt Vater C, Driscoll H, Faraone SV (2023). Growth Trajectories in Stimulant-Treated Children Ages 6 to 12: An Electronic Medical Record Analysis Journal of Developmental & Behavioral Pediatrics 44(2): p e80-e87. doi: 10.1097/DBP.0000000000001156
- Brikell I, Yao H, Li L, Astrup A, Gao L, Gillies MB, Xie T, Zhang-James Y, Dalsgaard S, Engeland S, Faraone SV, Haavik J, Hartman C, Ip P, Smári UJ, Larsson H, Man KKC, de Oliveira Costa J, Pearson SA, Nielsen N, Snieder H, Wimberley T, Wong ICK, Zhang L, Zoega H, Klungsøyr K, Chang Z (2023). ADHD medication discontinuation and persistence across the lifespan: a multinational study The Lancet Psychiatry. online 27 November 2023 https://doi.org/10.1016/S2215-0366(23)00332-2
- Callen EF, Clay TL, Alai J, Goodman DW, Adler LA, Shields J, Faraone SV (2023). Progress and Pitfalls in the Provision of Quality Care for Adults With Attention Deficit Hyperactivity Disorder in Primary Care Journal of Attention Disorders 27(6), 575–582. doi: 10.1177/10870547231155875
- Dehnavi AZ, Zhang-James Y, Draytsel D, Carguello B, Faraone SV, Weinstock RS (2023). Association of ADHD symptoms with type 2 diabetes and cardiovascular comorbidities in adults receiving outpatient diabetes care Journal of Clinical & Translational Endocrinology 32, 100318. doi: 10.1016/j.jcte.2023.100318
- Demontis D, Walters GB, Athanasiadis G, Walters R, Therrien K, Tollerup Nielsen T, Farajzadeh L, Voloudakis G, Bendl J, Zeng B, Zhang W, Grove J, Als TD, Duan J, Satterstrom FK, Bybjerg-Grauholm J, Bækved-Hansen M, Gudmundsson OO, Magnusson SH, Baldursson G, Davidsdottir K, Haraldsdottir GS, Agerbo E, Hoffman GE, Dalsgaard S, Martin J, Ribasés M, Boomsma DI, Artigas MS, Roth Mota N, Howrigan D, Medland SE, Zayats T, Rajagopal VM, ADHD Working Group of the Psychiatric Genomics Consortium, iPSYCH-Broad Consortium, Nordentoft M, Mors O, Hougaard DM, Mortensen PB, Daly MJ, Faraone SV, Stefansson H, Roussos P, Franke B, Werge T, Neale BM, Stefansson K & Børglum AD (2023). Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains nature genetics 55, 198-208. doi: 10.1038/s41588-022-01285-8
- Faraone SV, Childress AC, Gomeni R, Rafla E, Kando JC, Dansie L, Naik P, Pardo A (2023). Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day Journal of Child and Adolescent Psychopharmacology. 14-19. doi: 10.1089/cap.2022.0093
- Garcia‑Argibay M, Brikell I, Thapar A, Lichtenstein P, Lundström S, Demontis D & Larsson H. (2023). Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: Evidence From Multiple Genetically Informed Designs. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2023.07.017
- Garcia-Argibay M, Li L, Du Rietz E, Zhang L, Yao H, Jendle J, Ramos-Quiroga JA, Ribasés M, Chang Z, Brikell I, Cortese S, Larsson H (2023). The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study Neuroscience & Biobehavioral Reviews 147. doi: 10.1016/j.neubiorev.2023.105076
- Larsson H. (2023). How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease? Expert Review of Cardiovascular Therapy. https://doi.org/10.1080/14779072.2023.2279608
- Radonjić NV, Bellato A, Khoury NM, Cortese S, Faraone SV (2023) Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis CNS Drugs 37, 381–397. doi: 10.1007/s40263-023-01005-8
- Smari UJ, Valdimarsdottir UA, Aspelund T, Hauksdottir A, Thordardottir EB, Hartmann CA, Andell P, Larsson H, Zoega H (2023) Psychiatric comorbidities in women with cardiometabolic conditions with and without ADHD: a population‑based study BMC Medicine 21:450. doi: 10.1186/s12916-023-03160-7
- Zhang-James Y, Razavi AS, Hoogman M, Franke B, Faraone SV, (2023). Machine Learning and MRI-based Diagnostic Models for ADHD: Are We There Yet? Journal of Attention Disorders 24(4), 335–353. doi: 10.1177/10870547221146256
- Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D’Onofrio BM, Brikell I, Kuja-Halkola R, Lichtenstein P,Johnell K, Larsson H, Chang Z (2023) Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases JAMA Psychiatry. Published online November 22, 2023. doi:10.1001/jamapsychiatry.2023.4294
2022
- Bruno C, Havard A, Gillies MB, Coghill D, Brett J, Guastella AJ, Pearson S-A, Zoega H (2022). Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)The Australian and New Zealand Journal of Psychiatry. doi: 10.1177/00048674221114782
- Daly MJ, Singh, T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, Bass N, Bigdeli TB, Breen G, Bromet EJ, Buckley PF, Bunney WE, Bybjerg-Grauholm J, Byerley WF, Chapman SB, Chen WJ, Churchhouse C, Craddock N, Cusick CM, DeLisi L, Dodge S, Escamilla MA, Eskelinen S, Fanous AH, Faraone SV, Fiorentino A, Francioli S, Gabriel SB, Gage D, Gagliano Taliun SA, Ganna A, Genovese G, Glahn DC, Grove J, Hall MH, Hämäläinen E, Heyne HO, Holi M, Hougaard DM, Howrigan DP, Huang H, Hwu HG, Kahn RS, Kang HM, Karczewski KJ, Kirov G, Knowles JA, Lee FS, Lehrer DS, Lescai F, Malaspina D, Marder SR, McCarroll SA, McIntosh AM, Medeiros H, Milani L, Morley CP, Morris DW, Mortensen PB, Myers RM, Nordentoft M, O’Brien NL, Olivares AM, Ongur D, Ouwehand WH, Palmer DS, Paunio T, Quested D, Rapaport MH, Rees E, Rollins B, Satterstrom FK, Schatzberg A, Scolnick E, Scott LJ, Sharp SI, Sklar P, Smoller JW, Sobell JL, Solomonson M, Stahl EA, Stevens CR, Suvisaari J, Tiao G, Watson SJ, Watts NA, Blackwood DH, Børglum AD, Cohen BM, Corvin AP, Esko T, Freimer NB, Glatt SJ, Hultman CM, McQuillin A, Palotie A, Pato CN, Pato MT, Pulver AE, St Clair D, Tsuang MT, Vawter MP, Walters JT, Werge TM, Ophoff RA, Sullivan PF, Owen MJ, Boehnke M, O’Donovan MC, Neale BM. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 604, pages 509–516. doi: 10.1038/s41586-022-04556-w
- Denyer H, Ramos-Quiroga JA, Folarin A, Ramos C, Nemeth P, Bilbow A, Woodward E, Whitwell S, Müller-Sedgwick U, Larsson H, Dobson RJB, Kuntsi J,(2022). ADHD Remote Technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): a multi-centre prospective cohort study protocol BMC Psychiatry.22:813. doi: 10.1186/s12888-022-04429-6
- Dobrosavljevic M, Fazel S, Du Rietz E, Li L, Zhang L, Chang Z, Jernberg T, Faraone SV, Jendle J, Chen Q, Brikell I, Larsson H (2022). Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder .
- Garcia-Argibay M, Du Rietz E, Hartman CA, Lichtenstein P, Chang Z, Fava C, Cortese S, Larsson H (2022). Cardiovascular risk factors in attention deficit/hyperactivity disorder: A family design study of Swedish conscriptsInternational Journal of Methods in Psychiatric Research. 31(4):e1930. doi: 10.1002/mpr.1930.
- Garcia-Argibay M, du Rietz E, Lu Y, Martin J, Haan E, Lehto K, Bergen SE, Lichtenstein P, Larsson H & Brikell I (2022). The role of ADHD genetic risk in mid-tolate life somatic health conditionsTranslational Psychiatry. 12, 152. doi: 10.1038/s41398-022-01919-9
- Garcia-Argibay M, Zhang-James Y, Cortese S, Lichtenstein P, Larsson H & Faraone SV (2022). Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approachMolecular Psychiatry 28, 1232–1239. doi: 10.1038/s41380-022-01918-8
- Heslin KP, Haruna A, George RA, Chen S, Nobel I, Anderson KB, Faraone SV, Zhang-James Y (2022). Association Between ADHD and COVID-19 Infection and Clinical Outcomes: A Retrospective Cohort Study From Electronic Medical RecordsJournal of Attention Disorders. Jan;27(2):169-181. doi: 10.1177/10870547221129305.
- Hou, J, Hess JL, Armstrong N, Bis JC, Grenier-Boley B, Karlsson IK, Leonenko G, Numbers K, O’Brien EK, Shadrin A, Thalamuthu A, Yang Q, Andreassen OA, Brodaty H, Gatz M, Kochan NA, Lambert JC, Laws SM, Masters CL, Mather KA, Pedersen NL, Posthuma D, Sachdev PS, Williams J, Fan CC, Faraone SV, Fennema-Notestine C, Lin SJ, Escott-Price V, Holmans P, Seshadri S, Tsuang MT, Kremen WS, Glatt SJ (2022). Polygenic resilience scores capture protective genetic effects for Alzheimer’s diseaseTranslational Psychiatry. 12 (296). doi: 10.1038/s41398-022-02055-0
- Li L, Chang Z, Sun J, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, Brikell I, Jernberg T, Solmi M, Cortese S, Larsson H (2022). Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort studyWorld Psychiatry. 21 (3): pp. 452-459. doi: 10.1002/wps.21020
- Stenberg E, Larsson H, Marsk R, Cao Y, Sundbom M, Näslund E (2022). Association between Attention Deficit Hyperactivity Disorder and outcomes after metabolic and bariatric surgery: a nationwide propensity matched cohort studySurgery for Obesity and Related Diseases. 19(2): pp. 92-100. doi: 10.1016/j.soard.2022.10.028
- Zhang L, Yao H, Li L, du Rietz E, Andell P, Garcia-Argibay M, D’Onofrio BM, Cortese S, Larsson H (2022). Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysisJAMA Network Open. 2022;5(11):e2243597. doi:10.1001/jamanetworkopen.2022.43597
